0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Bone Cancer"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Oncology Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Oncology Collaboration and Licensing Deals 2019-2024

  • Report
  • October 2024
  • 1800 Pages
  • Global
From
EUR$3,995USDGBP
From
EUR$5,600USDGBP
Interventional Oncology Devices Market Report 2025 - Product Thumbnail Image

Interventional Oncology Devices Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
Cancer Cryotherapy Market Report and Forecast 2024-2032 - Product Thumbnail Image

Cancer Cryotherapy Market Report and Forecast 2024-2032

  • Report
  • August 2024
  • 200 Pages
  • Global
From
EUR$4,949USDGBP
From
EUR$4,750USDGBP
From
EUR$119USDGBP
EUR$127USDGBP
EUR$224USDGBP
  • 11 Results (Page 1 of 1)
Loading Indicator

Bone cancer is a type of cancer that affects the cells of the bones. It is a rare form of cancer, accounting for less than 1% of all cancers. It can occur in any bone in the body, but is most commonly found in the long bones of the arms and legs. Symptoms of bone cancer include pain, swelling, and tenderness in the affected area. Treatment options for bone cancer include surgery, chemotherapy, radiation therapy, and targeted therapy. The bone cancer market is a subset of the larger oncology market. It is a rapidly growing market, driven by advances in technology and treatments. The market is expected to continue to grow in the coming years, as new treatments and technologies are developed. Companies in the bone cancer market include Novartis, Pfizer, Merck, Bristol-Myers Squibb, and AstraZeneca. These companies are involved in the development and marketing of treatments for bone cancer. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more